The epigenetic code in depression: Implications for treatment

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 2, 2012, Pages 310-314

  Schroeder, M ^a,b   Hillemacher, T ^b   Bleich, S ^b   Frieling, H ^b  

^a GOETHE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ENTINOSTAT; HISTONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VORINOSTAT;

ANTIDEPRESSANT ACTIVITY; ARTICLE; DNA METHYLATION; ENZYME INHIBITION; EPIGENETICS; HUMAN; MAJOR DEPRESSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; DNA METHYLATION; DRUG DISCOVERY; EPIGENESIS, GENETIC; HISTONE DEACETYLASE INHIBITORS; HUMANS; MODELS, BIOLOGICAL;

EID: 84855912686     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.282     Document Type: Article

References (27)

1. Egger, G., Liang, G., Aparicio, A. & Jones, P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463 (2004). (Pubitemid 38715140)
2. Szyf, M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu. Rev. Pharmacol. Toxicol. 49, 243-263 (2009).
3. Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 (suppl.), 245-254 (2003). (Pubitemid 36278835)
4. Jeltsch, A. Molecular enzymology of mammalian DNA methyltransferases. Curr. Top. Microbiol. Immunol. 301, 203-225 (2006). (Pubitemid 43022673)
5. Jenuwein, T. & Allis, C.D. Translating the histone code. Science 293, 1074-1080 (2001). (Pubitemid 32758077)
6. Bhutani, N., Burns, D.M. & Blau, H.M. DNA demethylation dynamics. Cell 146, 866-872 (2011).
7. Liu, R.T. & Alloy, L.B. Stress generation in depression: A systematic review of the empirical literature and recommendations for future study. Clin. Psychol. Rev. 30, 582-593 (2010).
8. Caspi, A. et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389 (2003). (Pubitemid 36877077)
9. Caspi, A., Hariri, A.R., Holmes, A., Uher, R. & Moffitt, T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 167, 509-527 (2010).
10. Philibert, R.A., Sandhu, H., Hollenbeck, N., Gunter, T., Adams, W. & Madan, A. The relationship of 5-HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am. J. Med. Genet. Part B 147 B, 543-549 (2007). (Pubitemid 351961655)
11. van Ijzendoorn, M.H., Caspers, K., Bakermans-Kranenburg, M.J., Beach, S.R. & Philibert, R. Methylation matters: interaction between methylation density and serotonin transporter genotype predicts unresolved loss or trauma. Biol. Psychiatry 68, 405-407 (2010).
12. Weaver, I.C. et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847-854 (2004). (Pubitemid 38989508)
13. Weaver, I.C. et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J. Neurosci. 25, 11045-11054 (2005). (Pubitemid 41692634)
14. McGowan, P.O. et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12, 342-348 (2009).
15. Oberlander, T.F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S. & Devlin, A.M. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3, 97-106 (2008).
16. Uddin, M., Koenen, K.C., Aiello, A.E., Wildman, D.E., de los Santos, R. & Galea, S. Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample. Psychol. Med. 41, 997-1007 (2011).
17. Tan, J., Cang, S., Ma, Y., Petrillo, R.L. & Liu, D. Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J. Hematol. Oncol. 3, 5 (2010).
18. Warden, D., Rush, A.J., Trivedi, M.H., Fava, M. & Wisniewski, S.R. The STAR*D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9, 449-459 (2007). (Pubitemid 350284935)
19. Mill, J. & Petronis, A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol. Psychiatry 12, 799-814 (2007). (Pubitemid 47347791)
20. Tsankova, N.M., Berton, O., Renthal, W., Kumar, A., Neve, R.L. & Nestler, E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9, 519-525 (2006).
21. Covington, H.E. 3rd et al. Antidepressant actions of histone deacetylase inhibitors. J. Neurosci. 29, 11451-11460 (2009).
22. Roth, T.L., Lubin, F.D., Funk, A.J. & Sweatt, J.D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol. Psychiatry 65, 760-769 (2009).
23. LaPlant, Q. et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat. Neurosci. 13, 1137-1143 (2010).
24. Sales, A.J., Biojone, C., Terceti, M.S., Guimarães, F.S., Gomes, M.V. & Joca, S.R. Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br. J. Pharmacol. 164, 1711-1721 (2011).
25. Higuchi, F. et al. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. J. Psychiatr. Res. 45, 1295-1300 (2011).
26. Tsankova, N., Renthal, W., Kumar, A. & Nestler, E.J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355-367 (2007). (Pubitemid 46652469)
27. Grayson, D.R., Kundakovic, M. & Sharma, R.P. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol. Pharmacol. 77, 126-135 (2010).